New goals in hypertension management: Target-organ protection beyond blood pressure lowering;Nouveaux objectifs dans la prise en charge de l'hypertension: Au-delà de l'abaissement de la pression artérielle, la protection des organes-cibles

Drugs

Volumn 63, Issue SPEC. ISS. 1, 2003, Pages 45-47

  Safar, Michel E ^a   Struijker Boudier, Harry A J ^b  

^a HÔPITAL BROUSSAIS   (France)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTERIOLE; ARTERY COMPLIANCE; ARTERY STIFFNESS; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; BRAIN PROTECTION; CAPILLARY; CARDIOVASCULAR RISK; CONFERENCE PAPER; DRUG EFFICACY; HEART FUNCTION; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PROTECTION; PULSE PRESSURE; RESISTANCE BLOOD VESSEL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; ULTRASTRUCTURE; VASCULAR DISEASE; VENULE;

ANTIHYPERTENSIVE AGENTS; BRAIN; CARDIOVASCULAR DISEASES; CORONARY VESSELS; HEART; HUMANS; HYPERTENSION; KIDNEY; MICROCIRCULATION; VASCULAR RESISTANCE;

EID: 0345074082     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200363991-00006     Document Type: Conference Paper

References (12)

1. Danchin N. Pression pulsée et maladie coronaire. Arch Mal Cœur Vaiss 2002; 95 Spec. No. 6: 7-10
2. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-60
3. Nichols WW, O'Rourke MF, Hartley C, et al. McDonald's blood flow in arteries: theoretic, experimental, and clinical principles. 4th ed. London: E. Arnold, 1998
4. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6
5. Nishijima T, Nakayama Y, Tsumura K, et al. Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease. Am J Hypertens 2001; 14: 469-73
6. Boutouyrie P, Bussy C, Lacolley P, et al. Local steady and pulse pressure and arterial remodelling. Circulation 1999; 100: 1387-93
7. Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-92
8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13
9. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46
10. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-41
11. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-5
12. Safar ME. Mechanical factors predicting cardiovascular risk and drug treatment of hypertension. J Hypertens 2002; 20: 349-52